CLSN Is Hot & Newsy, CTMX Soars On AMGN Deal, SUNFISH Fails To Help PTCT Shine

Today's Daily Dose brings you news about Celsion's encouraging data from OVATION Study; CytomX' collaboration with Amgen; FDA approval of Mylan's generic Copaxone; pricing of NewLink's stock offering and encouraging data from PTC Therapeutics' SUNFISH trial.

from RTT - Biotech http://ift.tt/2ymVYLI
via IFTTT